Homepage / Technology / Finally, the first new drug for sickle cell anemia in 20 years
Menyelami Dunia Slot Thailand: Keseruan dan Peluang Kemenangan Besar Menyelami Dunia Slot Thailand: Pengalaman Bermain yang Tak Terlupakan Yatırım Şartsız Deneme Bonusları ile Hızlı Başlangıç Yapın Onwin Güncel Giriş Online Spor Bahis Siteleri 8359 onwin giriş Güncel Bonusları 1518 grandpashabet giriş Limelight ahead 5 The Majority Of Sought-After Classifications at JeetBuzz 1Win Sports Betting and Casino Official Site Login 1WIN casino official website of the bookmaker, slots, gaming machines 1win: Sitio web oficial del Casino y Casa de Apuestas 2024, Apuestas Deportivas en Línea, Inicio de sesión de 1win 1Win Apuestas Deportivas y Casino Online Bono 500% 1Win Apuestas Deportivas y Casino Online Bono 500% 1win: Sitio web oficial del Casino y Casa de Apuestas 2024, Apuestas Deportivas en Línea, Inicio de sesión de 1win Casino 1Win Argentina Reseña: Todo lo que necesitas saber sobre usabilidad y registro 1win: Sitio web oficial del Casino y Casa de Apuestas 2024, Apuestas Deportivas en Línea, Inicio de sesión de 1win Mines evaluation 1WIN casino official website of the bookmaker, slots, gaming machines 1win App Download 2025 1win apk & iOS download info! The Rise of TrumpCoin: A 2025 Digital Gold Rush 1WIN Sitio web oficial de Apuestas y Casino en línea Bonificación por inscripción $5000 1WIN bet cassino site oficial, slots, jogos de azar, apostas 1WIN bet cassino site oficial, slots, jogos de azar, apostas test-g Ghostwriting: Was ist erlaubt? 1WIN bet cassino site oficial, slots, jogos de azar, apostas Espejos acceso alternativo a los sitio Muchas personas se hacen ahora esta pregunta 10 Mejores Casinos Online en España Guía Actualizada 2025 Start meeting horny girls now – sign up today Find local adult chat sites and relate solely to fun singles generative ai course 1WIN Sitio web oficial de Apuestas y Casino en línea Bonificación por inscripción $5000 1Win Uruguay: Apuestas Deportivas y Casino Oficial The simplest way to meet up sexy women Bahis Sitelerinde Üyelik Bonusu Nasıl Alınır? Find an ideal match with lonely housewife hookup website Master the art of online dirty talk Yeni Başlayanlar İçin En İyi Bahis Siteleri ve Promosyonlar Casino Sitelerinde Hangi Bonuslar Daha Avantajlı? Deneme Bonusları ile Slot Oyunları: Oynamak İçin En İyi Siteler Experience a fantastic and unique option to satisfy brand new people Adjustment in Marriage: 10 Techniques For Newly Married Couples Güncel Bahis Siteleri: Bonus Fırsatları ve Yenilikler 2025’ün En İyi Bahis Stratejileri: Yüksek Oranlarla Kazanma Deneme Bonuslarıyla Oyunları Keşfet: En İyi Siteler Güncel Deneme Bonusları: Hangi Sitelerde Mevcut? Enjoy the greatest adult fuckbook experience now Mature bbw lesbians – find love utilizing the right partner เว็บพนัน ออนไลน์ จับกลางกรุง! บุกทลายฐานเว็บพนันชาวไต้หวันรายใหญ่ เงินหมุนเวียน 500 ล้าน ปี Panduan Lengkap Bermain Slot Online: Strategi & Tips Terbaik Deneme Bonusu ile Ücretsiz Oyun Oynayın Boy Names: Top 1,000 Baby Boy Names in the U S. for 2024 List of most popular given names Wikipedia Mobile Gaming in the UK: Trends, Regulations, and Future Leads Start dating hot moms today – it’s easier than you think Define generative ai 14 Define generative ai 14 How to find the right online gay dating website for you Home Superclones watches Exploring Super Clone Watches: Quality, Accuracy, and Affordability Join the most effective bbw milf dating site today En İyi Bahis Siteleri İçin Seçim Yaparken Nelere Dikkat Edilmeli? At this point, and yet very near | Life and magnificence | Trusted Casino Hellspin Review Leading Online Casino Hellspin Evaluation Mostbet App: Download Mostbet apk for Android & iOS 2024 Ігрові Автомати з Виводом Грошей на Карту ️ Онлайн Ігри на Гривні в Українікращі азартні ігри на гроші з виводом на карту2024-01-08 Taya365 online casino login Tips for conference and dating other bisexual men How to get the right bi partner Exploring the Prospering World of Online Casinos in the UK Meet hot singles and luxuriate in flirty chatting Bahis Siteleri: En İyi Bonuslar ve Promosyonlar Situs Slot Hari Ini Terbaik dan Terpercaya Tahun Ini, Gampang Menang Güvenilir Bonus Veren Siteler ve Detaylı İncelemeler Güncel Giriş, Güvenilir Adres VOX Casino: VOXCasino Promo Code 2025 Get to learn other old gay men inside area Slot Min Depo 10K Terbaik dan Paling Direkomendasi Tahun Ini: Gampang Menang! Scatter Hitam Terbaik dan Paling Direkomendasi Tahun Ini: Gampang Menang! Top 10 Online Casinos in Deutschland Januar 2025 Get ready to unleash your wildest fantasies Ücretsiz Oyun Deneyimi: Deneme Bonuslarıyla Risk Almadan Kazan Bonuslarla Bahis Keyfini Katlamanın Yöntemleri 2025’te Bahis Oynayarak Kazanç Sağlamanın Yolları Freespin Veren Casino Siteleri ile Daha Fazla Eğlenin Casino Sitelerinde En İyi Bonuslar Nerede? The Ultimate Guide to Free Spins BC.Game Mirror – Discover All Current Mirrors Find regional women seeking intimate encounters Elitecasino’a Katýlým saðlayarak, Hýzla 800 TL Bonus Ýmkaný Kazanýn! Baccarat Tips: Exactly How to Enhance Your Game and Boost Your Chances of Winning Find your perfect gay sex dating site Exploring 7slots in Turkey: A Comprehensive Overview Şartsız Deneme Bonusu Veren Sitelerin Listesi The Power of Tarot Online Free Finest Gambling Enterprises that Approve Bitcoin: The Future of Online Betting MostBet: Kumarhane Eðlencesiyle Dolu Eðlencenin Tadýný Çýkarmak MostBet: Kumarhane Oyunlarýyla Zengin Yeni Nesil Eðlence Deneyimi Understanding Clairvoyant Readings: A Comprehensive Overview Online Online Casinos That Accept PayPal: A Convenient and Secure Payment Choice Сайт казино Pin Up Tips for conference and connecting with seniors whom are interested in dating

Technology

Finally, the first new drug for sickle cell anemia in 20 years

In early July the Food and Drug Administration approved the first new drug for sickle cell patients in nearly 20 years. It was a watershed moment for people who suffer from the rare blood disorder that can cause debilitating pain. And for one physician it was the end of a 25-year journey.

The drug, Endari, is made by Emmaus and has been approved for patients five years and older. It injects glutamine into red blood cells, reducing the likelihood they will clog and cause painful blockages in small blood vessels and, in some cases, organs.

Sickle cell disease primarily affects African Americans, Latinos and other minority groups. It’s a lifelong disorder in which red blood cells, normally round, are crescent- (or sickle-) shaped, due to abnormal hemoglobin. That shape makes the cells less flexible, or more ‘sticky,’ which can impede blood flow. By injecting glutamine into the cells, Endari makes the cells less ‘sticky.’ It’s not a permanent solution, but it does help reduce the pain.

“We knew this was not going to cure the disease, but improve the conditions [for patients],” says Yutaka Niihara, MD, CEO of Emmaus. “We’re able to decrease the symptoms and make the circulation better.”

Sickle cell affects about 100,000 people in the United States, a number that’s dwarfed by people suffering from cancer, heart disease and other high-profile ailments. That number could actually be higher, but many patients are viewed as “drug seekers” by some members of the medical community, due to the severe pain they face. As a result, they may not be diagnosed with sickle cell.

More from Modern Medicine:
New hope for a vaccine to fight Gonorrhea
New tools to combat the organ transplant crisis
A.I.’s expanding role in medicine

Still, that official patient count made sickle cell an “orphan disease” in the eyes of most pharmaceutical companies, which ignored it for decades because of the perceived fear that development costs on any drugs would not be recouped.

Niihara first saw the disease in 1989, he says, when training in hemotology. He had planned to specialize in cancer, but after seeing sickle cell’s impact on patients, he changed his focus to researching the disease.

He first approached the FDA with the research for what would become Endari in 2000 and was given a $1 million grant to begin a Phase 2 clinical study.

From there, he says, he planned to pass it on to an established pharmaceutical company to continue the research, but he couldn’t find an interested company. As a result, he started Emmaus.

Now that Endari has received approval, he says, he intends to ensure it is an affordable drug so patients can relieve their suffering.

“Typically, the way pharmaceutical companies make money on a new medication is to charge enormous amounts of money for treatment,” he says. “Treatment for an orphan [disease] can cost $200,000 to $300,000 per year. Some can be more. That’s not our goal at all. We’re going to try to keep our price of a fully dosed patient below $20K. We’re sill finalizing pricing with our agency, but that’s what I’m asking.”

Emmaus, he says, has roughly an 85 percent margin on the product, so if it treats just 10
percent of the patients in the United States, it would result in more than $100 million in revenue.

“For a small biotech, that’s big money,” he says.

Should European approvals come, the market jumps to $2 billion, he says.

The approval of Endari has won praise from sickle cell advocacy groups, though they’re encouraging federal regulators and drug makers to speed up the pace of treatment research for the disease.

“More effort and resources still need to be dedicated to nutritional supplementation studies aimed at establishing specific RDAs (recommended dietary allowances) for sickle cell patients, much like the specific RDAs developed for cystic fibrosis, pregnancy and growth within the general population,” said Lanetta Bronté, president of the Foundation for Sickle Cell Disease Research.

Before the FDA’s approval of Endari, sickle cell patients most commonly were treated with Hydroxyurea, a drug that’s also used in chemotherapy. Endari, like any drug, has potential side effects. The FDA reported those could include constipation, nausea, headache, abdominal pain, cough, pain in the extremities, back pain and chest pain. But Niihara says, it doesn’t have toxicity.

“As a physician who is always facing sickle cell patients, I appreciated [Hydroxyurea], but at the same time, I wanted to provide something that doesn’t have toxicity — something where patients didn’t have to worry about birth defects or … worry they might develop cancer in the future.”

Endari may have broken a long drought in sickle cell treatments, but it could have lots of company soon. As of last year, there were a dozen other drugs still in development for the disease.

— By Chris Morris, special to CNBC.com

Source: Tech CNBC
Finally, the first new drug for sickle cell anemia in 20 years

Comments are closed.